IT1270647B - Solutions for the treatment of states of shock, in particular haemorrhagic shock - Google Patents
Solutions for the treatment of states of shock, in particular haemorrhagic shockInfo
- Publication number
- IT1270647B IT1270647B ITMI942068A ITMI942068A IT1270647B IT 1270647 B IT1270647 B IT 1270647B IT MI942068 A ITMI942068 A IT MI942068A IT MI942068 A ITMI942068 A IT MI942068A IT 1270647 B IT1270647 B IT 1270647B
- Authority
- IT
- Italy
- Prior art keywords
- shock
- treatment
- solutions
- states
- haemorrhagic
- Prior art date
Links
- 206010049771 Shock haemorrhagic Diseases 0.000 title abstract 2
- 230000035939 shock Effects 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 4
- 229920002307 Dextran Polymers 0.000 abstract 2
- 239000011780 sodium chloride Substances 0.000 abstract 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 abstract 1
- 229960003459 allopurinol Drugs 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
Landscapes
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Hypertonic aqueous solutions for the first aid treatment of shock conditions, in particular haemorrhagic shock, containing sodium chloride and dextran, characterized in that they comprise: from 5 to 10% and preferably from 6 to 8% sodium chloride, from 3 to 10% and preferably from 5 to 7% of dextran having a molecular weight of 40,000 to 70,000, from 30 to 60 and preferably from 40 to 50 mmol/l of sodium bicarbonate, and from 0.3 to 3 and preferably from 1 to 2 mmol/l of allopurinol. <IMAGE>
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI942068A IT1270647B (en) | 1994-10-11 | 1994-10-11 | Solutions for the treatment of states of shock, in particular haemorrhagic shock |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI942068A IT1270647B (en) | 1994-10-11 | 1994-10-11 | Solutions for the treatment of states of shock, in particular haemorrhagic shock |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI942068A0 ITMI942068A0 (en) | 1994-10-11 |
ITMI942068A1 ITMI942068A1 (en) | 1996-04-11 |
IT1270647B true IT1270647B (en) | 1997-05-07 |
Family
ID=11369687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI942068A IT1270647B (en) | 1994-10-11 | 1994-10-11 | Solutions for the treatment of states of shock, in particular haemorrhagic shock |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1270647B (en) |
-
1994
- 1994-10-11 IT ITMI942068A patent/IT1270647B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITMI942068A0 (en) | 1994-10-11 |
ITMI942068A1 (en) | 1996-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH31652A (en) | Dihydrolipoic acid as ophthalmological agent to suppress intolerable reactions in the aea between implants and living body tissue. | |
ZA898824B (en) | Aqueous ophthalmic solutions and method for preserving same | |
EP0927038A4 (en) | P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent | |
CA2008762A1 (en) | High salt content rapid disinfection solution for contact lenses | |
IT1270647B (en) | Solutions for the treatment of states of shock, in particular haemorrhagic shock | |
FR2691708B1 (en) | BIS-DITHIOPHOSPHORIC ACID DERIVATIVES AS ADDITIVES IN LUBRICANTS. | |
CA2198852A1 (en) | Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides | |
CA2020209A1 (en) | Low viscosity, highly concentrated surfactant suspension | |
CA2129043A1 (en) | Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema | |
GB9216506D0 (en) | Improvements in or relating to the treatment of sickle cell disease | |
FR2718923B1 (en) | Disinfecting composition in aqueous solution containing orthophthalaldehyde. | |
USD387665S (en) | Water cooler casing | |
CA2193405A1 (en) | Eyewash intended in particular for the treatment of the dry eye syndrome | |
ZA91614B (en) | Agent for use in the prevention,control or reversal of hypertension | |
FR2690330B1 (en) | DEVICE FOR TREATING CERTAIN FRACTURES LOCATED BETWEEN TROCHANTERIAL MASSIF AND 1/3 OF THE FEMALE DIAPHYSIS. | |
RU97108005A (en) | EYE DROPS "BALARPAN" | |
Cook | Sex role orientations and perceived parenting effectiveness | |
AU3274497A (en) | Hot-water extract of seaweed of the family spermatochnaceae and use thereof | |
FR2715025B1 (en) | Oyster pocket. | |
TJ288R3 (en) | 1,3,5,-Oxadiazin derivative or its tautomer in free form or in form of salt containing its insecticidal agent | |
ITMI942076A0 (en) | PROCEDURE FOR THE REDUCTION OF NICOTINE CONTENT THROUGH THE ACTION OF MICROORGANISMS | |
RU97116928A (en) | CLEANSING TOOL FOR THE BODY AND FACE "ATLAS LEATHER" | |
BG103211U (en) | Desensitive toothpaste | |
FR2762212B1 (en) | POTENTIALIZING THE EFFECT OF PHOTOACTIVE AGENTS BY BUTYRATE AND ITS DERIVATIVES | |
RU97113900A (en) | COMPOSITION FOR PREVENTION AND TREATMENT OF DENTAL CARIES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970902 |